The Board of Directors of Cordlife Group Limited announced the re-designation of Ms. Chen Xiaoling from Non-Independent Non-Executive Director to Group Executive Director with effect from 17 July 2024. As a Group Executive Director, Ms. Chen's immediate role focuses on addressing the critical challenges currently faced by the Company during this pivotal period. Her responsibilities include identifying and prioritizing these challenges, devising strategic solutions, and ensuring timely and effective implementation.

This involves closely collaborating with relevant stakeholders to mitigate risks, maintain operational stability, and support the Company's overall objectives amidst the challenges. Her efforts aim to foster resilience and steer the Company towards sustainable growth and success in the face of current difficulties. The Board of Directors comprises Dato' Dr. Teo Tong Kooi as Chairman and Independent Director (ID), Ms. Chen Xiaoling as Group Executive Director (GED), Mr. Zhai Lingyun, Mr. Yiu Ming Yiu, and Mr. Chow Wai Leong as Non-Independent Non-Executive Directors (NINED), and Mr. Cai Yong and Dr. Xu Tianhong as Independent Directors (ID).

The Audit and Risk Committee consists of Mr. Cai Yong (Chairman/ID), Mr. Yiu Ming Yiu (Member/NINED), and Dato' Dr. Teo Tong Kooi (Member/ID). The Nominating Committee includes Dato' Dr. Teo Tong Kooi (Chairman/ID), Ms. Chen Xiaoling (Member/GED), Mr. Yiu Ming Yiu (Member/NINED), Mr. Cai Yong (Member/ID), and Dr. Xu Tianhong (Member/ID). The Remuneration Committee is composed of Dato' Dr. Teo Tong Kooi (Chairman/ID), Ms. Chen Xiaoling (Member/GED), Mr. Chow Wai Leong (Member/NINED), Dr. Xu Tianhong (Member/ID), and Mr. Cai Yong (Member/ID).